Author:
Yang Daofeng,Wang Shuo,Zhu Huifen,Shen Guanxin
Publisher
Springer Science and Business Media LLC
Reference8 articles.
1. Crillo-Lopez AJ, White CA, Varns C, et al. Overview of the clinical development of rituximab: first monoclonal antibody approved for the treatment of lymphoma. Semin Oncol, 1999, 26(5 Suppl 14): 66–73.
2. Goldenberg MM. Trastuzumab, a recombinant DNA-derived humanized monoclonal antibody, a novel agent for the treatment of metastatic breast cancer. Clin Ther, 1999, 21(2): 309–318.
3. Thorson JA, Smith KM, Gomez F, et al. Role of iron in T cell activation: TH1 clones differ from TH2 clones in their sensitivity to inhibition of DNA synthesis caused by IgG Mabs against the transferrin receptor and the iron chelator deferoxamine. Cell Immunol, 1991, 134(1): 126–137.
4. Kemp JD. Iron deprivation and cancer: a view beginning with studies of monoclonal antibodies against the transferrin receptor. Histol Histopathol, 1997, 12(1): 291–296.
5. Kovar J, Stunz LL, Stewart BC, et al. Direct evidence that iron deprivation induces apoptosis in murine lymphoma 38C13. Pathobiology, 1997, 65(2): 61–68.
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献